Oxford Biomedica buys UK plant to cut reliance on CMO
Oxford Biomedica has bought RecipharmCobra Biologics’ manufacturing facility in Oxford, UK, to reduce its reliance on third-party production of its gene delivery technology.
Archives for February 1, 2011
Senior exec support key to supply chain change success
Supply chain strategy implementations are more likely to succeed when they have the active support of the board and senior executives, according to research.
Bayer buys into India with Zydus JV
German drugmaker Bayer has set its sights on expanding in the Indian drug market with the formation of a new joint venture with Zydus Cadila.
Parexel sees Q2 revenue grow, but cuts 2011 outlook
US contract research organisation (CRO) Parexel has cut its 2011 guidance, citing slower backlog conversion from projects generated by “strategic partnerships” as basis for the revision.
Increasingly bold outsourcing will help big pharma cut costs
Big pharma outsourcing will become much bolder in the next 12-18 months as companies attempt to “dramatically attack cost structures”, according to the Covance CEO.
Appointments at the USP, PDA and Merck KGaA – People on the move
in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including appointments at the USP, PDA and Merck KGaA.